Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients. [electronic resource]
Producer: 19920429Description: 112-4 p. digitalISSN:- 0277-3732
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Dacarbazine -- adverse effects
- Dexamethasone -- therapeutic use
- Diphenhydramine -- therapeutic use
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Male
- Melanoma -- drug therapy
- Methylprednisolone -- therapeutic use
- Metoclopramide -- therapeutic use
- Middle Aged
- Nausea -- chemically induced
- Sarcoma -- drug therapy
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.